Bone and Connective Tissue Cancer Archives - Page 2 of 10 - MPR

Bone and Connective Tissue Cancer

Lartruvo Approved for Soft Tissue Sarcoma


The Food and Drug Administration has granted accelerated approval to Lartruvo (olaratumab) injection with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS).

Outcomes of Daratumumab Tx Examined in Relapsed Multiple Myeloma

Daratumumab with bortezomib and dexamethasone is associated with longer progression-free survival in patients with relapsed or relapsed and refractory multiple myeloma, according to a study published in the August 25 issue of the New England Journal of Medicine.

Receiving Myeloma Immunotherapy Earlier May Have Greater Efficacy

Daratumumab (Darzalex), a recently approved immunotherapy drug for multiple myeloma, can provide better benefits if patients receive it earlier in their treatment, according to a study presented at the annual meeting of the American Society of Clinical Oncology, held in Chicago.

Unexpected Derm Diagnosis in Patient Treated with Dabrafenib

In a case report published online February 28 in the Journal of Clinical Pharmacy and Therapeutics, researchers document non-HIV-associated Kaposi sarcoma in a male patient with myasthenia gravis and metastatic melanoma treated with the BRAF inhibitor dabrafenib.